Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer cells condition lymphatic endothelial cells within pre-metastatic niches to promote metastasis
Authors
Keywords
-
Journal
Nature Communications
Volume 5, Issue 1, Pages -
Publisher
Springer Nature
Online
2014-09-02
DOI
10.1038/ncomms5715
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inhibition of Lymphangiogenesis and Angiogenesis in Breast Tumor Xenografts and Lymph Nodes by a Peptide Derived from Transmembrane Protein 45A
- (2015) Esak Lee et al. NEOPLASIA
- The IL-6/JAK/Stat3 Feed-Forward Loop Drives Tumorigenesis and Metastasis
- (2015) Qing Chang et al. NEOPLASIA
- Critical Role of STAT3 in IL-6–Mediated Drug Resistance in Human Neuroblastoma
- (2013) Tasnim Ara et al. CANCER RESEARCH
- Pre-treatment of mice with tumor-conditioned media accelerates metastasis to lymph nodes and lungs: a new spontaneous breast cancer metastasis model
- (2013) Esak Lee et al. CLINICAL & EXPERIMENTAL METASTASIS
- Epithelial to Mesenchymal Transition Promotes Breast Cancer Progression via a Fibronectin-dependent STAT3 Signaling Pathway
- (2013) Nikolas Balanis et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Stat3-Targeted Therapies Overcome the Acquired Resistance to Vemurafenib in Melanomas
- (2013) Fang Liu et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Stat3-coordinated Lin-28–let-7–HMGA2 and miR-200–ZEB1 circuits initiate and maintain oncostatin M-driven epithelial–mesenchymal transition
- (2013) L Guo et al. ONCOGENE
- Integrative Analysis of Complex Cancer Genomics and Clinical Profiles Using the cBioPortal
- (2013) J. Gao et al. Science Signaling
- STAT3-RANTES Autocrine Signaling Is Essential for Tamoxifen Resistance in Human Breast Cancer Cells
- (2012) E. H. Yi et al. MOLECULAR CANCER RESEARCH
- Role of STAT3 in Transformation and Drug Resistance in CML
- (2012) Rajesh R. Nair et al. Frontiers in Oncology
- Tumor Metastasis: Molecular Insights and Evolving Paradigms
- (2011) Scott Valastyan et al. CELL
- Cross-Talk between Tumor Cells and the Microenvironment at the Metastatic Niche
- (2011) M. J. Carlini et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Small peptides derived from somatotropin domain-containing proteins inhibit blood and lymphatic endothelial cell proliferation, migration, adhesion and tube formation
- (2011) Esak Lee et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Roles of STAT3 and ZEB1 Proteins in E-cadherin Down-regulation and Human Colorectal Cancer Epithelial-Mesenchymal Transition
- (2011) Hua Xiong et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
- (2011) Brian D. Lehmann et al. JOURNAL OF CLINICAL INVESTIGATION
- Endothelial FAK as a therapeutic target in disease
- (2011) Giovanni A. Infusino et al. MICROVASCULAR RESEARCH
- The lymphatic vasculature in disease
- (2011) Kari Alitalo NATURE MEDICINE
- Lymphangiogenesis: Molecular Mechanisms and Future Promise
- (2010) Tuomas Tammela et al. CELL
- Stat3-dependent acute Rantes production in vascular smooth muscle cells modulates inflammation following arterial injury in mice
- (2010) Jason C. Kovacic et al. JOURNAL OF CLINICAL INVESTIGATION
- The JAK2 Inhibitor AZD1480 Potently Blocks Stat3 Signaling and Oncogenesis in Solid Tumors
- (2009) Michael Hedvat et al. CANCER CELL
- Ethanol Augments RANTES/CCL5 Expression in Rat Liver Sinusoidal Endothelial Cells and Human Endothelial Cells via Activation of NF- B, HIF-1 , and AP-1
- (2009) S. M. Yeligar et al. JOURNAL OF IMMUNOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started